Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 13 recruiting now full pipeline

Acute Pain: full-pipeline trial registry

13 of 51 indexed Acute Pain trials are currently recruiting.

Corpus placement: #274 of 28,707 conditions by registered trial count.

51 US clinical trials · 13 currently recruiting · #274 of 28,707 conditions by registered trial count

Acute Pain: 51 US clinical trials tracked, 13 recruiting.

Acute Pain is the subject of 51 registered US clinical trials on ClinicalTrials.gov, 13 of them currently open to new participants. 13 are in Phase 3-4 (later-stage) and 17 in Phase 1-2 (earlier-stage). The most active sponsor is Montefiore Medical Center, running 3 of these trials.

Enrollment posture brief

Registry condition acute-pain

OPEN 13 | RECR 25% | LATE 13 | EARLY 17 | RANK #274 | SPON 3

Nearest open-share peer: Tobacco Use Disorder (25% recruiting · 75 trials)

Long COVID62.7%Peripheral Artery Disease54.9%Idiopathic Pulmonary Fibrosi42.3%Acute Pain (this)25%Congestive Heart Failure15.4%
Open-enrollment share among volume-matched conditions near Acute Pain

Acute Pain lists 13 open slots (25% of 51 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Acute Pain on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Acute Pain is recruiting below its size-band peers.

    13 of 51 indexed trials (25.5%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Acute Pain trials is spread across many organizations.

    Montefiore Medical Center accounts for 3 of 51 trials (5.9%). 42 distinct sponsors appear on at least one study for this condition label.

  3. Typical Acute Pain enrolment sits around 110 participants.

    Median target enrolment is 110 among the 51 trials that report a genuine target (sentinel values excluded). 22 of those (43.1%) plan for fewer than 100 participants.

  4. Acute Pain research is mostly interventional.

    42 interventional and 9 observational studies make up this index (82.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 15Phase 212Phase 310Phase 43

Open and recent trials

51 total, page 1 of 2

RECRUITING NA 3,500 participants

The Implementation of a Post-operative Communication App to Improve Pain Control and Opioid Use

University of Minnesota

NCT06124079

RECRUITING 1,000 participants

Understanding the Acute Pain Phenotype in Patients Undergoing Surgery

Brigham and Women's Hospital

NCT06466941

RECRUITING 800 participants

Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA

Brown University

NCT05754190

RECRUITING NA 400 participants

Does Patient Testimonial Improve the Pain Relief Derived From a Brief Intervention

Florida State University

NCT07335159

RECRUITING Phase 4 156 participants

Magnesium Infusion for Pain Management in Critically Ill Trauma Patients

University of California, Davis

NCT04166877

RECRUITING 100 participants

Characterization of Acute Pain

Children's National Research Institute

NCT07336264

RECRUITING NA 80 participants

Brief Mindfulness Intervention for Pain Before an In-clinic Orthopedic Procedure

Florida State University

NCT06471075

RECRUITING Phase 4 70 participants

Erector Spinae Plane Block Catheters and Intrathecal Morphine for Hepatic Resection

University of California, San Diego

NCT04849455

RECRUITING 60 participants

COA-APTIC Cognitive Interview Study of Caregiver and Clinician Assessment of Acute Pain in Infants and Young Children

Duke University

NCT06164028

RECRUITING Phase 2 48 participants

Twin Block, Pain Medications and Third Molar Extractions

Rutgers, The State University of New Jersey

NCT04880707

RECRUITING NA 30 participants

Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises

University of Maryland, Baltimore

NCT06184126

RECRUITING NA 25 participants

Evaluating the Impact of Focused Muscle Contraction Therapy in U.S. Veterans

University of Illinois at Chicago

NCT05094297

RECRUITING Phase 2 20 participants

Reducing Pain From Wisdom Molar Extractions

Rutgers, The State University of New Jersey

NCT05335070

ACTIVE NOT RECRUITING 220 participants

Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery

KK Women's and Children's Hospital

NCT03408717

ACTIVE NOT RECRUITING NA 70 participants

The Effect of Light Therapy on Post-Surgical Pain

University of Arizona

NCT03674697

ACTIVE NOT RECRUITING 50 participants

Evaluation of the Analgesic Efficacy of Multimodal Pain Control Regimens That Aim to Limit the Use of Narcotics in Cholecystectomy and Hernia Repairs

Methodist Health System

NCT06095453

ACTIVE NOT RECRUITING Phase 1 40 participants

Vasopressin and Pain Perception in the Brain

University of Maryland, Baltimore

NCT03446456

COMPLETED NA 1,602 participants

A Depression and Opioid Pragmatic Trial in Pharmacogenetics (Acute Pain Trial)

Duke University

NCT05966129

COMPLETED Phase 3 579 participants

Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy

Viatris Specialty

NCT06215859

COMPLETED Phase 3 418 participants

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy

Trevena

NCT02815709

COMPLETED Phase 3 350 participants

Clinical Trial Comparing Two Protocols Using Intravenous (IV) Hydromorphone

Montefiore Medical Center

NCT01311895

COMPLETED Phase 3 320 participants

Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain

Endo Pharmaceuticals

NCT00226395

COMPLETED Phase 2 303 participants

A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After an Abdominoplasty

Vertex Pharmaceuticals Incorporated

NCT05034952

COMPLETED Phase 2 298 participants

Safety of Hydromorphone in Adult Patients Presenting to the Emergency Department With Acute Severe Pain

Montefiore Medical Center

NCT00305110

COMPLETED Phase 2 274 participants

A Study Evaluating Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy

Vertex Pharmaceuticals Incorporated

NCT04977336

COMPLETED Phase 3 240 participants

A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy

Tris Pharma

NCT06423703

COMPLETED Phase 3 219 participants

Diclofenac Patch for Treatment of Acute Pain Due to Mild to Moderate Ankle Sprain

Cerimon Pharmaceuticals

NCT00869180

COMPLETED Phase 3 214 participants

Diclofenac Patch for the Treatment of Acute Pain Due to Mild to Moderate Wrist Sprain, Strain or Contusion

Cerimon Pharmaceuticals

NCT00869063

COMPLETED Phase 3 190 participants

Efficacy of XP20B Following Bunionectomy Surgery

Xanodyne Pharmaceuticals

NCT00655291

COMPLETED Phase 2 162 participants

Acetaminophen Versus IV Hydromorphone for Pain in the Elderly in the ED

Montefiore Medical Center

NCT03521102

COMPLETED NA 145 participants

Examination of Psychological and Physiological Pathways Linking Gratitude and Pain

Black Hills State University

NCT06317844

COMPLETED Phase 2 125 participants

Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain

iX Biopharma

NCT03246971

COMPLETED Phase 4 123 participants

Perioperative Gabapentin Use In Head And Neck Mucosal Surgery Patients

Washington University School of Medicine

NCT02926573

COMPLETED Phase 3 120 participants

Erector Spinae Block Versus Surgeon Infiltration in VATS Procedures

Indiana University

NCT03859635

COMPLETED NA 112 participants

Pharmacogenetic-guided Choice of Post-surgery Analgesics

University of Pennsylvania

NCT05548660

COMPLETED Phase 2 111 participants

Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.

Mylan Specialty

NCT05317312

COMPLETED 110 participants

Prospective Observational Clinical Study to Evaluate Patient Outcomes Following Pharmacogenetic Testing of Patients Undergoing Elective Surgical Procedures

AltheaDx

NCT02605343

COMPLETED Early Phase 1 100 participants

Efficacy of Gabapentin vs. Placebo for Adjuvant Pain Control Following Acute Rib Fractures

Denver Health and Hospital Authority

NCT02856750

COMPLETED NA 100 participants

Auricular Acupuncture for Acute Pain

Samueli Institute for Information Biology

NCT00253994

COMPLETED Phase 2 77 participants

Liposome Bupivacaine Interscalene Total Shoulder

University of Minnesota

NCT03587636

COMPLETED 72 participants

Comparison of Epidural and TAP Block in Abdominal Surgery

University of Nebraska

NCT01848951

COMPLETED NA 65 participants

NSS-2 BRIDGE Device in Post-Operative Pain Management

Jacques E. Chelly

NCT03555266

COMPLETED NA 60 participants

A Brief Intervention for Patients on Opioids for Acute Pain

Henry Ford Health System

NCT05658926

COMPLETED Phase 2 51 participants

A Phase 2 Study to Evaluate Analgesic Effect of IV CR845 For Pain Following Bunionectomy Surgery

Cara Therapeutics

NCT01789476

COMPLETED Phase 1 48 participants

A Phase 1, Randomized, Placebo-Controlled Safety and Tolerability Study Of Intravenous SBS-1000 in Healthy Adults

Sparian Biosciences

NCT05721287

COMPLETED Phase 2 36 participants

VR for Burn Dressing Changes at Home

Nationwide Children's Hospital

NCT04548635

COMPLETED 29 participants

The Use of Ultrasound to Measure Depth of Thoracic Epidural Space

University of Massachusetts, Worcester

NCT01172730

COMPLETED Phase 3 23 participants

Efficacy of Lidocaine Patch in Acute Musculoskeletal Pain in the Emergency Department

East Carolina University

NCT03571737

COMPLETED Phase 1 20 participants

Pupillary Unrest in Ambient Light, and Relationship to Opioid-Induced Respiratory Depression

University of California, San Francisco

NCT04301895

COMPLETED Early Phase 1 20 participants

The Influence of Testosterone on Experimental Pain Perception

University of New Mexi

NCT05781685

Page 1 of 2 Next →

Phase Distribution

PhaseTrial count
Phase 1 5
Phase 2 12
Phase 3 10
Phase 4 3

Named interventions

Most-linked intervention names on Acute Pain records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
9 trials
MR-107A-02 Drug
2 trials
Placebo (matched to HB/APAP) Drug
2 trials
Placebo (matched to VX-548) Drug
2 trials
HB/APAP Drug
2 trials
VX-548 Drug
2 trials
Pharmacogenetic testing Other
2 trials
Pain Psychoeducation Behavioral
2 trials

US sites by state

Facility locations filed on Acute Pain trials. A trial with sites in several states counts in each.

Texas 10 trials
California 10 trials
Utah 9 trials
Maryland 8 trials
Florida 6 trials
Arizona 6 trials
North Carolina 5 trials
Ohio 4 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Acute Pain page

51 registered trials, 13 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Pain condition card totals 51 registered trials; most-linked intervention Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.